Mepolizumab: all 66 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Mepolizumab and in Office-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS).RecruitingNCT07814924Phase 4
- Airway Dysfunction, Occlusions and Remodeling: COPD Patients and MepolizumabNot yet recruitingNCT07749001Phase 4
- Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPAEnrolling by invitationNCT07343661Phase 4
- th2 Modulation CRSwNPNot yet recruitingNCT06107101Phase 4
- Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study.Not yet recruitingNCT05923047Phase 4
- Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab TreatmentRecruitingNCT05642806Phase 4
- Immunological Basis for Mepolizumab Activity in COPDNot yet recruitingNCT05320939Phase 2
- A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPDCompletedNCT05138250Phase 3Results posted
- Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)CompletedNCT04965636Phase 3Results posted
- Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)CompletedNCT04823585Phase 4Results posted
- Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways DiseasesCompletedNCT04765722Phase 4Results posted
- Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)CompletedNCT04607005Phase 3Results posted
- Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic AsthmaCompletedNCT04276233Phase 4Results posted
- Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 AntagonistsCompletedNCT04183192Phase 1Results posted
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil LevelCompletedNCT04133909Phase 3Results posted
- Mepolizumab in Episodic Angioedema With EosinophiliaTerminatedNCT04128371Phase 2Results posted
- Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialCompletedNCT04075331Phase 2/3Results posted
- Mepo for Eosinophilic Esophagitis (EoE) StudyCompletedNCT03656380Phase 2Results posted
- Mepolizumab for the Treatment of Chronic Spontaneous UrticariaCompletedNCT03494881Early Phase 1Results posted
- A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622CompletedNCT03306043Phase 3Results posted
- Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921CompletedNCT03298061Phase 3Results posted
- A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban ChildrenCompletedNCT03292588Phase 2Results posted
- Study of Mepolizumab Autoinjector in AsthmaticsCompletedNCT03099096Phase 3Results posted
- Effect of Mepolizumab in Severe Bilateral Nasal PolypsCompletedNCT03085797Phase 3Results posted
- Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03055195Phase 2Results posted
- Study of Mepolizumab Safety Syringe in AsthmaticsCompletedNCT03021304Phase 3Results posted
- Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)CompletedNCT02836496Phase 3Results posted
- Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma PatientsCompletedNCT02654145Phase 4Results posted
- Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma PatientsCompletedNCT02555371Phase 3Results posted
- Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in ChildrenCompletedNCT02377427Phase 2Results posted
- Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma ControlCompletedNCT02281318Phase 3Results posted
- A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic SubjectsCompletedNCT02135692Phase 3Results posted
- Efficacy and Safety of Mepolizumab as an Add-on Treatment in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02105961Phase 3Results posted
- Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT02105948Phase 3Results posted
- A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With PolyangiitisCompletedNCT02020889Phase 3Results posted
- A Study to Determine Long-term Safety of Mepolizumab in Asthmatic SubjectsCompletedNCT01842607Phase 3Results posted
- MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic SubjectsCompletedNCT01691859Phase 3Results posted
- Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory AsthmaCompletedNCT01691521Phase 3Results posted
- Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory AsthmaCompletedNCT01691508Phase 3Results posted
- Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic BronchitisCompletedNCT01463644Phase 3Results posted
- Dose Ranging Pharmacokinetics and Pharmacodynamics Study With Mepolizumab in Asthma Patients With Elevated EosinophilsCompletedNCT01366521Phase 2Results posted
- Mepolizumab in Nasal PolyposisCompletedNCT01362244Phase 2Results posted
- Eosinophilic Airway Inflammation and MepolizumabCompletedNCT00802438Not applicableResults posted
- Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss SyndromeCompletedNCT00527566Phase 1/2Results posted
- Intravenous Mepolizumab In Children With Eosinophilic EsophagitisCompletedNCT00358449Phase 2Results posted
- Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic SyndromeTerminatedNCT00097370Phase 3Results posted
- REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive StudyActive, not recruitingNCT06041386Phase 4
- A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal PolypsActive, not recruitingNCT05942222Phase 4
- Identifying Predictors Of Response To Mepolizumab In CRSwNPActive, not recruitingNCT05902325Phase 4
- The Role of IL5 in Epithelial Cell IntegrityCompletedNCT05895929Early Phase 1
- Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male SubjectsCompletedNCT05576454Phase 1
- Mepolizumab Effectiveness in Severe Eosinophilic Asthma and BronchiectasisStatus unknownNCT05189613Not applicable
- Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)CompletedNCT05030155Phase 3
- Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".Status unknownNCT04585997Phase 4
- Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and CytokinesCompletedNCT04412044Phase 4
- Mepolizumab for Eosinophilic FasciitisWithdrawnNCT04305678Phase 1
- A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in BrazilStatus unknownNCT04228588Phase 4
- Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY StudyTerminatedNCT02594332Phase 3
- Anti-IL-5 Therapy in Bullous Pemphigoid (BP)CompletedNCT01705795Phase 2
- Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsStatus unknownNCT01520051Phase 3
- Japanese Phase 1 Study of MepolizumabCompletedNCT01471327Phase 1
- Safety and Efficacy Study of Mepolizumab in Churg Strauss SyndromeCompletedNCT00716651Phase 2
- The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)CompletedNCT00292877Phase 2
- An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult PatientsCompletedNCT00274703Phase 2
- Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic SyndromeCompletedNCT00266565Phase 1/2
- Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)CompletedNCT00086658Phase 3